New York is planning to loosen its marijuana laws to allow limited use of the drug by people suffering serious illness, the New York Times reported Saturday, citing state officials.
The Taiwan branch of the multinational pharmaceutical firm GlaxoSmithKline (GSK) yesterday donated
Some 3,000 more Cuban doctors are to arrive in Brazil from Monday to join a government program to fill vacancies in the country's public health system.
What do Siberian tigers and older women have in common?
Parents should limit kids' tweeting and texting and keep smartphones and laptops out of bedrooms, a pediatricians group says.
U.S. Food and Drug Administration advisers on Friday unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions infected with the liver-destroying virus.
The European Medicines Agency (EMA) on Friday rejected a French request to tighten prescription guidelines on types of birth-control pills linked with a relatively higher risk of blood clots.
ScinoPharm Taiwan (台灣神隆) on Monday announced its new active pharmaceutical ingredient (API) for treating epilepsy has been ratified and launched by Supernus Pharmaceuticals in the U.S. market last week.
Taiwan's biotechnology sector yesterday saw a rapid decline, with the industry index losing 2.7 percent on the Taiwan Stock Exchange (TWSE), and down 3.3 percent on the over-the-counter-GreTai Securities Market. This was coupled with rocking reports concerning the beleaguered Legislative Yuan Speaker Wang Jin-pyng, who may be deposed before he can carry out policy amendments designed to benefit the sector.